Calcium long term

Keywords Alzheimer disease, calcium, long term potentiation, cognition, transgenic, amyloid beta... 

Calcium Absorption. Phytates in cereal grains have also been reported to interfere with the absorption of calcium. However, a long-term study indicated a retention of calcium in subjects that consume large amounts of bread made with high extraction of flour (19). 

The various lubricants formulated into PVC to improve the processing can also enhance the performance of the stabilizet. In pigmented apphcations, calcium soaps, eg, calcium stearate, ate commonly used as internal lubricants to promote PVC fusion and reduce melt viscosity. This additive is also a powerfiil costabilizer for the alkyl tin mercaptide stabilizers at use levels of 0.2 to 0.7 phr. Calcium stearate can significantly improve the eady color and increase the long-term stabiUty at low levels however, as the concentration increases, significant yellowing begins to occur. 

Coatings, Paints, and Pigments. Various slightly soluble molybdates, such as those of zinc, calcium, and strontium, provide long-term corrosion control as undercoatings on ferrous metals (90—92). The mechanism of action presumably involves the slow release of molybdate ion, which forms an insoluble ferric molybdate protective layer. This layer is insoluble in neutral or basic solution. A primary impetus for the use of molybdenum, generally in place of chromium, is the lower toxicity of the molybdenum compound. 

Silver alone on a support does not give rise to a good catalyst (150). However, addition of minor amounts of promoter enhance the activity and the selectivity of the catalyst, and improve its long-term stabiHty. Excess addition lowers the catalyst performance (151,152). Promoter formulations have been studied extensively in the chemical industry. The most commonly used promoters are alkaline-earth metals, such as calcium or barium, and alkaH metals such as cesium, mbidium, or potassium (153). Using these metals in conjunction with various counter anions, selectivities as high as 82—87% were reported. Precise information on commercial catalyst promoter formulations is proprietary (154—156). 

Half-lives span a very wide range (Table 17.5). Consider strontium-90, for which the half-life is 28 a. This nuclide is present in nuclear fallout, the fine dust that settles from clouds of airborne particles after the explosion of a nuclear bomb, and may also be present in the accidental release of radioactive materials into the air. Because it is chemically very similar to calcium, strontium may accompany that element through the environment and become incorporated into bones once there, it continues to emit radiation for many years. About 10 half-lives (for strontium-90, 280 a) must pass before the activity of a sample has fallen to 1/1000 of its initial value. Iodine-131, which was released in the accidental fire at the Chernobyl nuclear power plant, has a half-life of only 8.05 d, but it accumulates in the thyroid gland. Several cases of thyroid cancer have been linked to iodine-131 exposure from the accident. Plutonium-239 has a half-life of 24 ka (24000 years). Consequently, very long term storage facilities are required for plutonium waste, and land contaminated with plutonium cannot be inhabited again for thousands of years without expensive remediation efforts. 

In Figure 8.2, for the purpose of examining the effeet of variable calcium, the Sr/Ca ratios of all the plants were set to the same fixed value (0.00790). In nature this situation is rarely likely to exist because there is intrinsic vari-abihty among different plant species (Runia 1987, 1988). The fact that bone represents a long-term (ca. 7 years) dietaiy average somewhat obviates this somce of variability. To the extent, however, that the dietaiy selection of plants varies systematically, the dietary Sr/Ca ratio will reflect this difference. Consistent dietaiy differences in the selection of plants are likely to affect bone Sr/Ca, especially since plants will usually be the dominant source of calcium. It should be noted that one of the earliest paleodietary apphcations of bone... 

Thus the neurotransmitter role of ATP is well established in the periphary and also in sensory systems but its importance in the CNS remains to be elucidated (see Burnstock 1996). That requires the development of more specific antagonists and methods of mapping its location. The strong linkage of its P2x receptors to calcium currents may also provide a role for ATP in more long-term effects such as plasticity and neuronal development and death. 

FIGURE 6-6. Decision algorithm for long-term ventricular rate control with oral drug therapy for patients with paroxysmal or permanent atrial fibrillation, bpm, beats per minute CCB, calcium channel blocker (diltiazem or verapamil) HF, heart failure LV, left ventricular function LVEF, left ventricular ejection fraction. (Algorithm adapted with permission from Tisdale JE, Moser LR. Tachyarrhythmias. In Mueller BA, Bertch KE, Dunsworth TS, et al. (eds.) Pharmacotherapy Self-Assessment Program, 4th ed. Kansas City American College of Clinical Pharmacy 2001 ... 

Patients with IBD, particularly those with CD, are also at risk for bone loss. This may be a function of malabsorption or an effect of repeated courses of corticosteroids. Patients with IBD should receive a baseline bone density measurement prior to receiving corticosteroids. Vitamin D and calcium supplementation should be used in all patients receiving long-term corticosteroids. Oral bisphosphonate therapy may also be considered in patients receiving prolonged courses of corticosteroids or in those with osteopenia or osteoporosis. 

BMD will increase and the risk of fractures will decrease in women taking HRT. However, when therapy is discontinued, a decline in BMD will resume at the same rate as in women not on HRT. Therefore, therapy for osteoporosis prevention should be considered long term. Since HRT should be maintained only for the short term, alternative therapies such as bisphosphonates or raloxifene should be considered as first-line therapy for the prevention of postmenopausal osteoporosis, in addition to appropriate doses of calcium and vitamin D. Because of the risks associated with HRT, it should not be prescribed solely for the prevention of osteoporosis. 

Some calcium products contain lead.12 While the clinical significance and long-term risks are unknown, it is best to use supplements without a high lead content. Because of the number of calcium supplements available, patients may find it overwhelming to choose a supplement. Health care providers can help... 

---